5th Annual ADC Summit

SMi is delighted to announce that its 5th ADC Summit will take place on 23rd - 24th May in London, UK.Registration to the conference is now live.

With the FDA's recent approval of ADCs Adcetris and Kadcyla, the industry has never been moving faster. New innovations in developing the next best generation ADCs are bursting into the clinic at a rapid rate.

SMi's ADC Summit 2016 provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.

Join leading industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

Remember to register to 2 half-day post-conference workshops:

WORKSHOP A: ADC Payloads: Availability and Mechanisms of Action hosted by Femtogenix and King's College London

WORKSHOP B: Developments in High Potency Manufacturing hosted by SKAN AG